Neuroprotective activity of Matricaria recutita Linn against global model of ischemia in rats

Journal of Ethnopharmacology

Volumn 127, Issue 3, 2010, Pages 645-651

  Chandrashekhar, V M ^a   Ranpariya, V L ^a   Ganapaty, S ^b   Parashar, A ^a   Muchandi, A A ^a  

^a Shri BVVSangha's Hanagal Shri Kumareshwar College of Pharmacy   (India)

^b ANDHRA UNIVERSITY   (India)

Author keywords

Cerebrovascular diseases; Chamomile; Ischemia reperfusion; Matricaria recutita L.; Neuroprotection; Oxidative stress

Indexed keywords

CATALASE; CHAMOMILE; COUMARIN DERIVATIVE; FLAVONOID; GLUTATHIONE; METHANOL; NEUROPROTECTIVE AGENT; QUERCETIN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TANNIN DERIVATIVE; TERPENOID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; FEMALE; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYMES; FEMALE; INFLORESCENCE; LIPID PEROXIDATION; MALE; MATRICARIA; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

MATRICARIA RECUTITA; RATTUS;

EID: 76149127636     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.12.009     Document Type: Article

References (46)

1. Albert Y.S., Yong-Mei C. Oxidative stress and neurodegenerative disorders. Journal of Biomedical Science 1998, 5:401-414.
2. Alexi T., Borlongan C., Faull C., Williams C., Clark R., Gluckman P., Hughes P. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Progress in Neurobiology 2000, 60:409-470.
3. Anonymous, 1998. From what will we die in 2020? (Editorial). Lancet 349, 1263-1264.
4. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986, 17:1304-1308.
5. Braughler J.M., Chase R.L., Pregenzer J.F. Oxidation of ferrous iron during peroxidation of various lipid substrates. Biochimica Biophysica Acta 1987, 921:457-464.
6. Cao W., Carney J.M., Duchon A., Floyd R.A., Chevion M. Oxygen free radical involvement in ischemia and reperfusion injury to brain. Neuroscience Letters 1998, 88:233-238.
7. Claiborne A. Catalase activity. CRC Hand Book of Methods for Oxygen Radical Research 1985, 283-284. CRC Press, Boca Raton, Florida, USA. R.A. Greenwald (Ed.).
8. Danbolt N.C. Glutamate uptake. Progress in Neurobiology 2001, 65:1-105.
9. Dringen R. Metabolism and functions of glutathione in brain. Progress in Neurobiology 2000, 62:649-671.
10. Dugan L.L., Choi D.W. Hypoxic-ischemic brain injury and oxidative stress. Basic Neurochemistry 1999, 637-669. Lippincott-Raven Publishers, Philadelphia. G.J. Siegel, B.W. Agranoff, R.W. Alber, S.K. Fischer, M.D. Uhler (Eds.).
11. Farbiszewski R., Bielawski K., Bielawska A., Sobaniec W. Spermine protects in vivo the antioxidant enzymes in transiently hypoperfused rat brain. Acta Neurobiologica Experimentalis 1995, 55:253-258.
12. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. American Journal of Medicine 1991, 91:14S-22S.
13. Huang Y., McNamara J.O. Ischemic stroke: " Acidotoxicity" is a perpetrator. Cell 2004, 118:665-670.
14. Jabaudon D., Scanziani M., Gahwiler B.H., Gerber U. Acute decrease in net glutamate uptake during energy deprivation. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:5610-5615.
15. Jenner P. Oxidative damage in neurodegenerating diseases. Lancet 1994, 344:796-798.
16. Khynriam D., Prasad S.B. Changes in endogenous tissue glutathione level in relation to murine ascites tumor growth and the anticancer activity of cisplatin. Brazilian Journal of Medical and Biological Research 2003, 36:53-63.
17. Kinouchi H., Epstein C.J., Mizui T., Carlson E., Chen S.F., Chan P.H. Attenuation of focal cerebral ischemic injury in transgenic mice over expressing CuZn superoxide dismutase. Proceeding of National Academy of Sciences 1991, 88:11158-11162.
18. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. Journal of Pharmacology and Experimental Therapeutics 1949, 96:99-113.
19. Liu H., Beckman J.S., Freeman B.A., Hogan E.L., Hsu C.Y. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. American Journal of Physiology 1989, 256:H589-H593.
20. Lowry O.H., Rosebrough N.J., Fair A.L., Randall R.J. Protein measurement with Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-275.
21. Martens D. Chamomile: the herb and the remedy. The Journal of the Chiropractic Academy of Homeopathy 1995, 6:15-18.
22. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. The Journal of Nutrition 2000, 130:1007-1015.
23. Misra H.P., Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and a sample assay for superoxide dismutase. Journal of Biological Chemistry 1972, 247:3170-3175.
24. Morimoto T., Globus M.Y., Busto R., Martinez E., Ginsberg M.D. Simultaneous measurement of salicylate hydroxylation and glutamate release in the penumbral cortex following transient middle cerebral artery occlusion in rats. Journal of Cerebral Blood Flow and Metabolism 1996, 16:92-99.
25. Moron A., De Pierre J.W., Mannervick B. Levels of glutathione, glutathione reductase, glutathione-S-transferase activities in rat liver. Biochimica et Biophysica Acta 1979, 582:67-68.
26. Nakashima M., Niwa M., Iwai T., Uematsu T. Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat. Free Radical Biology and Medicine 1999, 26:722-729.
27. Newall C.A., Anderson L.A., Phillipson J.D. Herbal Medicines: A Guide For Health-Care Professionals 1996, Pharmaceutical Press, London.
28. Nicholis D., Attwell D. The release and uptake of excitatory amino acids. Trends in Pharmacological Sciences 1990, 11:462-468.
29. Nicotera P., Lipton S. Excitotoxins in neuronal apoptosis and necrosis. Journal of Cerebral Blood Flow and Metabolism 1999, 19:583-591.
30. Norris J.W., Hachinski V.C. Stroke prevention: past, present and future. Prevention of Stroke 1993, 1-15. Springer-Verlag, New York. J.W. Norris, V.C. Hachinski (Eds.).
31. Ottersen O.P., Laake J.H., Reichelt W., Haug F.M., Torp R. Ischemic disruption of glutamate homeostasis in brain: quantitative immunocytochemical analysis. Journal of Chemical Neuroanatomy 1996, 12:1-14.
32. Picq M., Dubois M., Munri-Silem Y., Prugent A.F., Pacheco H. Flavonoid modulation of protein kinase C activation. Life Sciences 1989, 44:1563-1571.
33. Prabhakar K.R., Veerapur V.P., Vipan P.K., Priyadarsini K.I., Rao B.S.S., Unnikrishnan M.K. Evaluation and optimization of radio protective activity of Coronopus didymus Linn. in γ-irradiated mice. International Journal of Radiation Biology 2006, 82:525-536.
34. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischemia is mainly by reversed uptake. Nature 2000, 403:316-321.
35. Salaman I. Chamomile: a medicinal plant. The Herb, Spice, and Medicinal Plant Digest 1992, 10:1-4.
36. Schulz J.B., Lindenau J., Seyfried J., Dichgans J. Glutathione, oxidative stress and neurodegeneration. European Journal of Biochemistry 2000, 267:4904-4911.
37. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and non-protein sulfhydryl groups in tissue with Ellman's reagent. Analytical Biochemistry 1968, 25:192-205.
38. Shah Z.A., Gilani R.A., Sharma P., Vohora S.B. Cerebroprotective effect of Korean ginseng tea against global and focal models of ischemia in rats. Journal of Ethnopharmacology 2005, 101:299-307.
39. Solaroglu I., Okutan O., Kaptanoglu E., Beskonakli E., Kilinc K. Increased xanthine oxidase activity after traumatic brain injury in rats. Journal of Clinical Neuroscience 2005, 12:273-275.
40. Spranger M., Krempien S., Schwab S., Donneberg S., Hacke W. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury; correlation with clinical course and infarct size. Stroke 1997, 28:2425-2428.
41. Tagaya M., Matsumoto M., Kitagawa K., Niinobe M., Ohtsuki T., Hata R., Ogawa S., Handa N., Mikoshiba K., Kamada T. Recombinant SOD can attenuate ischemic neuronal damage in gerbils. Life Sciences 1992, 51:253-259.
42. Trease G.E., Evans W.C. Pharmacognosy 1989, Bailliere Tindall, London, pp. 683-684. 13th ed.
43. Viglino P., Scarpa M., Rotilio G., Rigo A. A kinetic study of the reactions between H2O2 and Cu-Zn superoxide dismutase, evidence for an electrostatic control of the reaction rate. Biochemistry Biophysics Acta 1988, 952:77-82.
44. Wade S.S., Johnson S.C., Easton J.D. Cerebrovascular disease. Principle's of Internal Medicine 2005, vol. II. McGraw-Hill, pp. 2372.
45. Welch K.M.A., Kaplan L.R., Reis D.J., Siesjo B.K., Weir B. Primer on Cerebrovascular Diseases 1997, Academic Press, San Diego, CA, USA.
46. Yu Z.F., Bruce-Keller A.J., Goodman Y., Mattson M.P. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. Journal of Neuroscience Research 1998, 53:613-625.